Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CLN.SW and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CLN.SW and 80,000+ other tickers.
See exactly how CLN.SW's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CLN.SW and 80,000+ other tickers.
Clariant AG operates as a global leader in specialty chemicals, organized into three primary business units: Care Chemicals, Catalysis, and Natural Resources. The company develops and supplies a broad spectrum of chemical products and solutions. This includes fire retardants, performance-enhancing additives, and advanced surface treatments for applications spanning plastics, coatings, inks, and consumer goods. It also provides essential catalysts for petrochemical and fuel refining, synthesis gas, general chemical processes, and emissions control, along with specialized zeolite and custom…
No recent news available.